BoZo Research Center Inc. supports optimizing lead compounds.
This page provides a detailed overview of their non-clinical study capabilities, examples of disease models, and case studies.
It serves as a useful reference when selecting a CRO(contract research organization).
BoZo Research Center Inc. offers comprehensive non-clinical testing service for a wide range of drug development projects, including in pharmaceuticals, agrochemicals, and food products.
Their service encompasses pharmacological, toxicological, and analytical studies by specialists in each field.
They provide consistent support from the early drug discovery phase to commercialization phase.
The center has a proven track record in providing non-clinical studies.They are especially recognized for their research in cancer and metabolic diseases, offering extensive in vivo and in vitro testing using various disease models.
Consulting services by the team of experts are also available.
Non-clinical studies at BoZo Research Center Inc. are conducted with a strong commitment to animal welfare, following the 3R (Replacement, Reduction, and Refinement) principles.
The center is fully accredited by AAALAC International, and all of their facilities are compliant to GLP standards, which ensures that studies are performed in a safe and ethical environment.
It is essential to go through the testing of candidate compounds in animal models that reproduce the target disease before advancing to clinical trials.
However, clinically relevant disease models may not always exist, thus there are demands for animal models with strong clinical correlation.
Below are some examples of disease models offered at Ina Research.
Guinea pigs sensitized with OVA are used to evaluate drug effects on acute/chronic nasal reactions—such as rhinitis and nasal obstruction—induced by intranasal antigen administration, as well as on inflammatory cell infiltration in the nasal cavity.
Rats can also be used for efficacy studies on increased vascular permeability in the nasal mucosa.
Guinea pigs sensitized with OVA are used to examine drug effects on acute/chronic asthmatic reactions and airway obstruction induced by antigen inhalation, as well as on inflammatory cell infiltration in the airway lumen.
Mouse models are also available to investigate airway hyperresponsiveness and airway remodeling.
Pharmacological and medical device performance evaluations are also available by experienced researchers at BoZo Research Center Inc..
There are models for rhinitis, asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis.
For COPD evaluations, various pathological models are available, including tobacco solution administration models (guinea pigs) and tobacco smoke exposure models (mice, rats, and guinea pigs).
BoZo Research Center Inc. provides tailored solutions that meet the needs of pharmaceutical companies, medical device manufacturers, academic institutions, bio-ventures, and medical organizations.
| Address | 36-7 Oyama-cho, Shibuya-ku, Tokyo |
|---|---|
| Tel | 03-5453-8101 |
| Website | https://www.bozo.co.jp/ |
In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D.
In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening.
Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.